GKOS Stock: Price, Earnings History and SEC Filings
Glaukos Corporation (GKOS) last traded at $237.60, down 2.01% on the latest session and up 44.7% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.47 against an analyst estimate of $-0.12, a beat of 491.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GKOS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $0.47 | $-0.12 | +491.67% |
| Jun 2026 | Jul 29, 2026 | $-0.14 | $-0.28 | +50.00% |
| Mar 2026 | Apr 29, 2026 | $-0.18 | $-0.30 | +40.00% |
| Dec 2025 | Feb 17, 2026 | $-0.28 | $-0.22 | -27.27% |
GKOS beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How GKOS reacts to earnings
Across its last 8 earnings releases, GKOS moved 14.1% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | After close | +33.65% |
| 2026-07-29 | After close | +4.24% |
| 2026-04-29 | After close | +22.84% |
| 2026-02-17 | After close | +13.47% |
| 2026-01-13 | After close | -5.26% |
| 2025-10-29 | After close | +13.89% |
| 2025-07-30 | After close | -8.46% |
| 2025-04-30 | After close | -11.36% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
GKOS financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $507M | -$188M | -$22M | -37.0% | $-3.28 |
| 2024 | $383M | -$146M | -$68M | -38.2% | $-2.77 |
| 2023 | $315M | -$135M | -$78M | -42.8% | $-2.78 |
| 2022 | $283M | -$99M | -$63M | -35.1% | $-2.09 |
| 2021 | $294M | -$50M | -$23M | -16.9% | $-1.07 |
| 2020 | $225M | -$120M | -$30M | -53.5% | $-2.70 |
| 2019 | $237M | $15M | -$5M | 6.5% | $0.37 |
| 2018 | $181M | -$13M | $9M | -7.1% | $-0.37 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for GKOS
- 10-Q · Oct 28, 2026
- 8-K · Oct 28, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 3, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Jul 29, 2026
- 8-K · Jul 29, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jun 3, 2026Shareholder vote
- 8-K · May 4, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Apr 30, 2026
- 8-K · Apr 29, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- DEF 14A · Apr 16, 2026
Insider filing activity
GKOS insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
GKOS news
- Okta Stock Can Find More Buyers as It Joins the S&P 500Oct 30, 2026 · finance.yahoo.com
- Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600Oct 30, 2026 · finance.yahoo.com
- SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutOct 30, 2026 · finance.yahoo.com
- Glaukos (GKOS) Earnings, Outlook ‘Brighter’; Shares Soar to All-Time HighOct 30, 2026 · finance.yahoo.com
- Glaukos (GKOS) Stock Charges Higher On Q3 Earnings SurpriseOct 30, 2026 · finance.yahoo.com
- Glaukos Sets $1 Billion 2027 Sales Goal: Rapid Earnings ReactionOct 29, 2026 · fool.com
- Why Glaukos Stock Is Surging 30% and Headed for Record Close After EarningsOct 29, 2026 · finance.yahoo.com
- West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook RaisedOct 29, 2026 · finance.yahoo.com
About Glaukos Corporation
Glaukos Corporation (GKOS) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.